doi 10.1186/s12876-023-02716-4 88 AzmyNabeh OIshak AttallahMElSayed ElGawharyN
The mean change in body weight from baseline to week 104 was -15.2% in the semaglutide group (n = 152) versus -2.6% with placebo (n = 152), for an estimated treatment difference of -12.6 %-points (95% confidence interval, -15.3 to -9.8
3d and 3f, g), which might result in progressively greater loss of cell surface receptors over time, despite similar acute endocytosis rates
GLP-1s for Osteoarthritis GLP-1 drugs may slow the progression of osteoarthritis, as research has found that people on the drugs lost more weight and had fewer knee surgeries than people not taking a GLP-1
If they arent neutralized, they may damage your mitochondrias DNA, which may lead to aging, low energy, and fatigue, says Staheli